Locations:
SearchHighlights from the 2014 Medical Innovation Summit
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/679d9029-087d-4147-a161-844ee277af88/Live-from-Innovations_690x380_jpg)
Live from Innovations_690x380
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Video content: This video is available to watch online.
View video online (//www.youtube.com/embed/lvGNzOn6oOE?rel=0&wmode=transparent )
As cancer care becomes more population-based, standardizing treatment regimens, reducing variability and optimizing outcomes are essential for cost efficiency. Cleveland Clinic Taussig Cancer Institute Chairman Brian Bolwell, MD, explains.
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients